Presentation - Pharmacy Technician Pulse

Lomecel-B CLEARMIND Phase 2a Trial Results to Be Presented at AAIC

Pharmacy Times

JULY 18, 2024

Safety and efficacy findings on Lomecel-B will be presented at the upcoming 2024 Alzheimer’s Association International Conference, which will be held July 28 to August 1.

What States are Doing to Regulate Pharmacy Benefit Managers

Drug Topics

MARCH 25, 2024

In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers assessed state-level regulations for PBMs.

Obesity is Common in Individuals with Celiac Disease

Drug Topics

MAY 23, 2024

In an abstract presented at Digestive Disease Week 2024, researchers analyzed the prevalence of obesity in patients with and without celiac disease.

Chronic Hand Eczema Studies Show Condition is Common, Burdensome

Drug Topics

SEPTEMBER 9, 2024

LEO Pharma presented data from 2 of the largest multinational real-world studies on the prevalence, severity and treatment of chronic hand eczema at the European Society of Contact Dermatitis congress.

Presentation and Diagnosis of Primary Biliary Cholangitis

Pharmacy Times

DECEMBER 18, 2024

Panelists discuss how primary biliary cholangitis (PBC) often presents asymptomatically but can be diagnosed through elevated alkaline phosphatase levels, positive antimitochondrial antibodies, and liver biopsy when necessary.

Spotlight On The Infectious Diseases Podcast Over 15 Years Old That Just Added New Mobile Streaming Options

IDStewardship

JUNE 18, 2023

Adopting the name, “ IDPodcasts ,” the project (the term “podcast” was coined by a BBC journalist in 2004) sought to adapt infectious diseases presentations to a format recently popularized by the popular iPod music player of the 2000’s. A second tab features the newest uploaded podcast presentations.

Hospitals

Assessing How COVID-19 Impacted Pharmacists’ Work Activities, Job Satisfaction

Drug Topics

MARCH 27, 2024

Two posters presented at APhA 2024 examined how the COVID-19 pandemic impacted pharmacists and their work.

Continuous Glucose Monitors Help Reduce A1c in Patients with Diabetes

Drug Topics

JULY 1, 2024

Research presented at the American Diabetes Association 84th Scientific Sessions suggests a population approach to CGM use could be beneficial.

Clinical Presentation in Patients With Lymphoma Widely Vary, Making Treatment Difficult

Pharmacy Times

AUGUST 9, 2024

A variety of signs and symptoms of lymphoma were reported, including fever, stomach discomfort, and weight loss.

Examining Antibiotic Allergies, Pharmacists Role in Testing

Drug Topics

MARCH 25, 2024

Researchers presented their findings on hypersensitivity caused by antibiotics as well as the best ways pharmacists can test for it.

COVID-19 Infection Raises Heart Failure Risks, Underlines Vaccination Importance

Drug Topics

OCTOBER 8, 2024

Research presented at CHEST 2024 outlined the heart failure risks associated with COVID-19 infection and emphasized the importance of vaccination to prevent adverse outcomes.

Vaccines

Pharmacy Education Must Keep Pace With Changing Health Care Landscape | ACCP 2024

Drug Topics

OCTOBER 16, 2024

Posters presented at ACCP 2024 revealed gaps in pharmacy students’ understanding of off-label drug applications and identified strengths and weaknesses among pharmacy graduates.

Labelling

Experts say leaked messages present false link between gender-affirming care and cancer

STAT

MARCH 11, 2024

Hundreds of messages from an internal chat board for an international group of transgender health professionals were leaked in a think tank report last week and framed as revealing serious health risks associated with gender-affirming care, including cancer.

STAT+: Genentech, a biotech with a storied past, confronts new turbulence in the present

STAT

SEPTEMBER 16, 2024

For decades, the biotech company Genentech has carved out a reputation in the industry as a scientist’s paradise, a place where researchers have developed new therapies in-house and published high-impact papers.

GLP-1s, SGLT2 Inhibitors Reduce Progression of CKD

Drug Topics

JUNE 14, 2024

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

Slideshow: Pharmacists’ Ability to Improve Patient Care in Cancer Medication Management Services

Drug Topics

APRIL 5, 2024

In 4 posters presented at the Hematology/Oncology Pharmacy Association Annual Conference 2024, researchers addressed pharmacists’ role in managing patients’ anticancer medications.

Patient Care

Slideshow: The Role of CGM in Diabetes Management During Pregnancy

Drug Topics

JANUARY 29, 2024

Three posters being presented at the Society for Maternal-Fetal Medicine 44th Annual Pregnancy Meeting examined the impact of continuous glucose monitoring on pregnancy outcomes.

Slideshow: Innovation in Diabetes Technology Could Improve Disease Management

Drug Topics

JUNE 26, 2024

At ADA 2024, researchers presented findings from 4 studies that investigated the impact of various new diabetes technologies on managing the condition.

Addressing The Need for Better Access to CGM in Low-Income Areas

Drug Topics

MARCH 26, 2024

In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers addressed continuous glucose monitoring and its potential role in indigent communities.

Omega-3 Fatty Acids May Lower Colorectal Cancer Risk

Drug Topics

MAY 21, 2024

Research presented at Digestive Disease Week suggests that including omega-3 rich foods, or omega-3 supplements, into a healthy diet could offer additional protection against colorectal cancer alongside regular screening.

ChatGPT Provides Inaccurate Responses to Questions About Drug Information

Drug Topics

DECEMBER 7, 2023

Two posters presented at ASHP 2023 Midyear examined how accurate answers were from the artificial intelligence chatbot.

Examining Pharmacists Role in the Current Vaccine Landscape

Drug Topics

MARCH 26, 2024

Posters presented at the APhA 2024 Annual Meeting and Exposition discussed pharmacist barriers in pediatric immunizations, a novel meningococcal vaccine, and the need for inpatient reviews of vaccination history.

Vaccines

Vaccines Immunization

Psilocybin Side Effects Found to be Tolerable, Resolve Within 2 Days

Drug Topics

MARCH 22, 2024

Results from a meta-analysis on the side of effects of the psychedelic psilocybin were presented at the 2024 American Pharmacists Association Annual Meeting & Exposition.

ASHP Midyear: High Costs of Gene Therapies Present Major Challenges to Implementation

Pharmacy Times

DECEMBER 11, 2024

According to the report, 75% of survey participants expect pharmacists to oversee these therapies and 58% expect Medicare will require pharmacist involvement.

How to Turn Patient Visits into Clinical Encounters in the Pharmacy | NCPA 2024

Drug Topics

OCTOBER 31, 2024

Presenters at the National Community Pharmacists Association 2024 Annual Convention and Expo discussed workflow and the future of pharmacy as a patient destination.

Prescription Drugs in the US Must Be Viewed as Critical Infrastructure | ASPL 2024

Drug Topics

NOVEMBER 9, 2024

Stephen Schondelmeyer, PharmD, PhD, FAPhA, gave a presentation on US drug shortages and their global implications.

Study: Higher Risk of Mental Health Conditions Present in Patients With an Aneurysm Diagnosis

Pharmacy Times

AUGUST 30, 2024

Those with an aneurysm diagnosis who were younger than 40 years of age were observed to have an even higher risk.

Daratumumab Plus VRd Improves Progression Free Survival in Newly Diagnosed Multiple Myeloma

Drug Topics

DECEMBER 13, 2023

Results of the phase 3 PERSEUS study were presented at the 2023 ASH Annual Meeting and Exposition.

Instagram Could Serve as Educational Platform for New FDA Drug Approvals

Drug Topics

DECEMBER 4, 2023

An evaluative study on an open resource Instagram page that provides information on new medications to pharmacists was recently presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition.

FDA

Exploring Alternative Pain Management Strategies for Headaches and Migraines | AMCP Nexus 2024

Drug Topics

OCTOBER 23, 2024

New research presented at AMCP Nexus 2024 highlighted the effectiveness and cost-effectiveness of various migraine treatments, including onabotulinumtoxinA and fremanezumab, as well as the importance of migraine education programs for improving patient outcomes.

Assessing B-Cell Maturation Antigen Directed Therapies in Multiple Myeloma Treatment

Drug Topics

DECEMBER 18, 2023

Three posters presented at the 65th American Society of Hematology Annual Meeting and Exposition looked into the efficacy and safety of the therapies.

STAT+: Recursion presents mixed data on lead AI-derived drug candidate for potentially fatal brain condition

STAT

SEPTEMBER 3, 2024

Recursion Pharmaceuticals announced results of a clinical trial for its lead drug candidate Tuesday that, while a success on paper, likely won’t satisfy many investors closely watching the AI drug developer.

Examining the State of Benzoyl Peroxide-Containing Acne Products After Benzene Contamination

Drug Topics

APRIL 10, 2024

Christopher Bunick, MD, PhD, FAAD, an associate professor of dermatology and a physician-scientist at the Yale School of Medicine in New Haven, Connecticut, presented updates on benzene in BPO at the 2024 American Academy of Dermatology Annual Meeting.

Mental Health Awareness Month: Fighting the growing mental health crisis and supporting innovation

PhRMA

MAY 11, 2023

Mental Health Awareness Month, which is held each year in May, presents an opportunity to discuss ways to address the growing burden of, and stigma surrounding, mental illness.

Juvenile Idiopathic Inflammatory Myopathies Following COVID-19 Infection

Drug Topics

NOVEMBER 23, 2022

In a recent study, racial minorities of an older age with non-classic cutaneous manifestations were more often to present with juvenile idiopathic inflammatory myopathies after COVID-19 infection.

Fourth Dose of COVID Vaccine Produced Milder Symptoms In Patients With IBD

Drug Topics

MAY 24, 2023

Data presented at Digestive Disease Week show that patients with IBD had less intense post-vaccination symptoms after a fourth dose.

Vaccines

House Energy and Commerce Committee presents own 2-year telehealth extension, with more rural health wins

Fierce Healthcare

MAY 15, 2024

The Energy and Commerce Committee released telehealth extension legislation today that will be voted on during a health subcommittee markup Thursday. | The House Energy and Commerce health subcommittee will hold a markup May 16 that includes a different two-year telehealth extension proposal than the Ways and Means Committee passed last week.

Poor Sleep in Premenopausal and Perimenopausal Women Linked to Migraine History

Drug Topics

OCTOBER 18, 2022

History of migraine may be associated with poor sleep in premenopausal and perimenopausal women, according to research presented at the North American Menopause Society Annual Meeting.

How To Mitigate Anorexia and Bulimia in Adolescents With Type 1 Diabetes

Drug Topics

APRIL 17, 2023

At the 44th National Association of Pediatric Nurse Practitioners Conference, a session presented data explaining why teenagers with T1D are at high risk for developing anorexia and bulimia.

Tirzepatide Demonstrates 94% Diabetes Reduction, 22% Weight Loss in SURMOUNT-1 Study

Drug Topics

AUGUST 21, 2024

A detailed report of study findings will be published in a peer-reviewed journal and presented at ObesityWeek 2024.

ICYMI: PhRMA COO Lori Reilly Esq. speaks with Jacob Van Naarden about the future of cancer research

PhRMA

NOVEMBER 8, 2022

Cancer event, hosting the session PhRMA Presents: The Future of Fighting Cancer. Our health care ecosystem has made tremendous progress in the fight against cancer, with the cancer death rate falling 32% from its peak in 1991. On November 3, PhRMA sponsored The Atlantic’s People v. PhRMA’s COO Lori Reilly, Esq.,

Slideshow: Exploring Cannabis Utilization in the Oncology Landscape

Drug Topics

JUNE 21, 2024

Four abstracts presented at ASCO 2024 delved into cannabis and pain management, potential medication interactions, and symptom mitigation, in patients with cancer.

The Power of Analytics for Pharmacy Service Marketing

Drug Topics

AUGUST 1, 2023

Mehrdad Hariri, RPh, CPh, MBA presented a session at July's Total Pharmacy Solution Summit on all the ways you can leverage those data for success. How many different ways can analytics assist your pharmacy? More than you may think.

STAT+: From Epic to FDA, all the leaders presenting at HHS’ invite-only AI in health care event

STAT

SEPTEMBER 17, 2024

Federal health officials wrestling with when and how to use artificial intelligence will on Wednesday host an invitation-only meeting of AI leaders across industry, academia, and government. Called “AI in Action: Transforming Health and Human Services,” the three-hour event is hosted by the federal health department.

Medical Schools

Medical Schools FDA Hospitals

Lomecel-B CLEARMIND Phase 2a Trial Results to Be Presented at AAIC

What States are Doing to Regulate Pharmacy Benefit Managers

Trending Sources

Obesity is Common in Individuals with Celiac Disease

Chronic Hand Eczema Studies Show Condition is Common, Burdensome

Presentation and Diagnosis of Primary Biliary Cholangitis

Spotlight On The Infectious Diseases Podcast Over 15 Years Old That Just Added New Mobile Streaming Options

Assessing How COVID-19 Impacted Pharmacists’ Work Activities, Job Satisfaction

Continuous Glucose Monitors Help Reduce A1c in Patients with Diabetes

Clinical Presentation in Patients With Lymphoma Widely Vary, Making Treatment Difficult

Examining Antibiotic Allergies, Pharmacists Role in Testing

COVID-19 Infection Raises Heart Failure Risks, Underlines Vaccination Importance

Pharmacy Education Must Keep Pace With Changing Health Care Landscape | ACCP 2024

Experts say leaked messages present false link between gender-affirming care and cancer

STAT+: Genentech, a biotech with a storied past, confronts new turbulence in the present

GLP-1s, SGLT2 Inhibitors Reduce Progression of CKD

Slideshow: Pharmacists’ Ability to Improve Patient Care in Cancer Medication Management Services

Slideshow: The Role of CGM in Diabetes Management During Pregnancy

Slideshow: Innovation in Diabetes Technology Could Improve Disease Management

Addressing The Need for Better Access to CGM in Low-Income Areas

Omega-3 Fatty Acids May Lower Colorectal Cancer Risk

ChatGPT Provides Inaccurate Responses to Questions About Drug Information

Examining Pharmacists Role in the Current Vaccine Landscape

Psilocybin Side Effects Found to be Tolerable, Resolve Within 2 Days

ASHP Midyear: High Costs of Gene Therapies Present Major Challenges to Implementation

How to Turn Patient Visits into Clinical Encounters in the Pharmacy | NCPA 2024

Prescription Drugs in the US Must Be Viewed as Critical Infrastructure | ASPL 2024

Study: Higher Risk of Mental Health Conditions Present in Patients With an Aneurysm Diagnosis

Daratumumab Plus VRd Improves Progression Free Survival in Newly Diagnosed Multiple Myeloma

Instagram Could Serve as Educational Platform for New FDA Drug Approvals

Exploring Alternative Pain Management Strategies for Headaches and Migraines | AMCP Nexus 2024

Assessing B-Cell Maturation Antigen Directed Therapies in Multiple Myeloma Treatment

STAT+: Recursion presents mixed data on lead AI-derived drug candidate for potentially fatal brain condition

Examining the State of Benzoyl Peroxide-Containing Acne Products After Benzene Contamination

Mental Health Awareness Month: Fighting the growing mental health crisis and supporting innovation

Juvenile Idiopathic Inflammatory Myopathies Following COVID-19 Infection

Fourth Dose of COVID Vaccine Produced Milder Symptoms In Patients With IBD

House Energy and Commerce Committee presents own 2-year telehealth extension, with more rural health wins

Poor Sleep in Premenopausal and Perimenopausal Women Linked to Migraine History

How To Mitigate Anorexia and Bulimia in Adolescents With Type 1 Diabetes

Tirzepatide Demonstrates 94% Diabetes Reduction, 22% Weight Loss in SURMOUNT-1 Study

ICYMI: PhRMA COO Lori Reilly Esq. speaks with Jacob Van Naarden about the future of cancer research

Slideshow: Exploring Cannabis Utilization in the Oncology Landscape

The Power of Analytics for Pharmacy Service Marketing

STAT+: From Epic to FDA, all the leaders presenting at HHS’ invite-only AI in health care event

Stay Connected